Repeal of Section 507 of the Federal Food, Drug and Cosmetic Act _1
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 15, 1998
May 26, 2020
2e6eed29-aedc-4122-900b-0eb9b1f9aaf0
Related Documents
Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations
Guidance DocumentSeptember 1, 1997Center for Drug Evaluation and Research
Alternate Source of the Active Pharmaceutical Ingredient in Pending ANDAs: Guidance for Industry
Guidance DocumentDecember 1, 2000Center for Drug Evaluation and Research
Dissolution Testing of Immediate Release Solid Oral Dosage Forms
Guidance DocumentAugust 25, 1997Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox